↓ Skip to main content

Methylenetetrahydrofolate Reductase Polymorphisms and Risk of Acute Lymphoblastic Leukemia-Evidence from an updated meta-analysis including 35 studies

Overview of attention for article published in BMC Medical Genomics, September 2012
Altmetric Badge

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
23 Mendeley
Title
Methylenetetrahydrofolate Reductase Polymorphisms and Risk of Acute Lymphoblastic Leukemia-Evidence from an updated meta-analysis including 35 studies
Published in
BMC Medical Genomics, September 2012
DOI 10.1186/1471-2350-13-77
Pubmed ID
Authors

Haigang Wang, Jiali Wang, Lixia Zhao, Xinchun Liu, Wenjie Mi

Abstract

5,10-methylenetetrahydrofolate reductase (MTHFR) variants, C677T and A1298C, have been reported to be associated with decreased risk of acute lymphoblastic leukemia (ALL). However, results derived from individually underpowered studies are conflicting. We carried out an updated meta-analysis on the association between MTHFR polymorphisms and ALL risk.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 4%
Unknown 22 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 22%
Other 2 9%
Researcher 2 9%
Student > Doctoral Student 2 9%
Student > Bachelor 2 9%
Other 6 26%
Unknown 4 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 8 35%
Medicine and Dentistry 7 30%
Biochemistry, Genetics and Molecular Biology 3 13%
Unknown 5 22%